Abstract

In 1998, a contract was signed between the University of California at Berkeley (UCB) and Novartis in which the latter agreed to give UCB's Department of Plant and Microbial Biology US$25 million over a five year period. This Agreement was the foundation for debates that split the university over issues related to corporate control of the university, the environmental and social consequences of biotechnology, intellectual property rights, and academic freedom. This paper investigates the ways in which the Agreement was presented within the public relations office of UCB and the popular press, as well as reactions to that coverage. Data were collected through archival and web-based searches and interviews with individuals connected to the Agreement.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.